LANDOS BIOPHARMA INC's ticker is LABP and the CUSIP is 515069102. A total of 21 filers reported holding LANDOS BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | – | 611 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 611 | -72.7% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 2,242 | +29.9% | 0.00% | – |
| Q2 2022 | $1,000 | -99.8% | 1,726 | -99.4% | 0.00% | – |
| Q1 2022 | $432,000 | -70.0% | 292,377 | -2.4% | 0.00% | – |
| Q4 2021 | $1,438,000 | -68.2% | 299,616 | -3.3% | 0.00% | -100.0% |
| Q3 2021 | $4,526,000 | +4.6% | 309,992 | -17.3% | 0.00% | 0.0% |
| Q2 2021 | $4,329,000 | +19.9% | 374,830 | -0.1% | 0.00% | – |
| Q1 2021 | $3,611,000 | – | 375,021 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 1,827,478 | $2,696,000 | 2.05% |
| Perceptive Advisors | 14,869,915 | $21,933,000 | 0.44% |
| RTW INVESTMENTS, LP | 4,275,722 | $6,307,000 | 0.13% |
| ArchPoint Investors | 128,750 | $190,000 | 0.07% |
| Orbimed Advisors | 283,217 | $418,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,000 | $235,000 | 0.01% |
| Walleye Capital LLC | 93,533 | $138,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 158,875 | $234,000 | 0.00% |
| Renaissance Technologies | 340,500 | $502,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,324 | $3,000 | 0.00% |